Paper766682
Isoniazid liver injury: clinical spectrum, pathology, and probable pathogenesis.
Mitchell JR and 6 others. Ann Intern Med, 1976. Cited by 460 papers, by iCite.
Cite this record
ConductScience Library. Isoniazid liver injury: clinical spectrum, pathology, and probable pathogenesis. Papers, record 766682. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/766682
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Chemical and Drug Induced Liver Injury | Major topic |
| Isoniazid | Major topic |
| Liver | Major topic |
| Acetylation | |
| Adult | |
| Aged | |
| Alanine Transaminase | |
| Animals | |
| Antibodies, Antinuclear | |
| Aspartate Aminotransferases | |
| Female | |
| Humans | |
| Hydrazines | |
| Male | |
| Middle Aged | |
| Phenotype |
Source PubMed
Cited by119
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 460 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42466481 | Validation of an UHPLC-MS/MS Assay for the Quantification of Isoniazid and Four Major Metabolites in Human Plasma. | Biomed Chromatogr | 2026 | https://conductscience.org/library/papers/42466481 | PubMed |
| 41323558 | Unraveling the Role of CYP2E1 in Antitubercular Drug-Induced Hepatotoxicity: From Molecular Mechanisms to Clinical Implications. | Int J Hepatol | 2025 | https://conductscience.org/library/papers/41323558 | PubMed |
| 40879696 | Deploying the drug repurposing approach for the identification of selective monoamine oxidase-B inhibitors against neurological disabilities: an in Silico and in vitro approach. | J Comput Aided Mol Des | 2025 | https://conductscience.org/library/papers/40879696 | PubMed |
| 40237651 | Hepatotoxicity Among People With HIV and Receiving Isoniazid Preventive Therapy in Pregnancy and Postpartum: The Role of Antiretroviral Regimen and Pharmacogenetics. | Clin Infect Dis | 2026 | https://conductscience.org/library/papers/40237651 | PubMed |
| 39959342 | Clinical perspectives of isoniazid-induced liver injury. | Liver Res | 2021 | https://conductscience.org/library/papers/39959342 | PubMed |
| 39364056 | Isoniazid-historical development, metabolism associated toxicity and a perspective on its pharmacological improvement. | Front Pharmacol | 2024 | https://conductscience.org/library/papers/39364056 | PubMed |
| 39165235 | Effect of chronic kidney disease on adverse drug reactions to anti-tubercular treatment: a retrospective cohort study. | Ren Fail | 2024 | https://conductscience.org/library/papers/39165235 | PubMed |
| 39085767 | Drug-induced hepatotoxicity and association with slow acetylation variants NAT2*5 and NAT2*6 in Cameroonian patients with tuberculosis and HIV co-infection. | BMC Infect Dis | 2024 | https://conductscience.org/library/papers/39085767 | PubMed |
| 38884784 | Polymorphism of CYP3A4*18 is associated with anti-tuberculosis drug-induced hepatotoxicity. | Pharmacogenomics | 2024 | https://conductscience.org/library/papers/38884784 | PubMed |
| 36500699 | Quantitative Analysis of Isoniazid and Its Four Primary Metabolites in Plasma of Tuberculosis Patients Using LC-MS/MS. | Molecules | 2022 | https://conductscience.org/library/papers/36500699 | PubMed |
| 36003040 | Pharmacokinetic and toxicodynamic concepts in idiosyncratic, drug-induced liver injury. | Expert Opin Drug Metab Toxicol | 2022 | https://conductscience.org/library/papers/36003040 | PubMed |
| 34872459 | Study on the associations between liver damage and antituberculosis drug rifampicin and relative metabolic enzyme gene polymorphisms. | Bioengineered | 2021 | https://conductscience.org/library/papers/34872459 | PubMed |
| 34545082 | Isonicotinylation is a histone mark induced by the anti-tuberculosis first-line drug isoniazid. | Nat Commun | 2021 | https://conductscience.org/library/papers/34545082 | PubMed |
| 33807700 | Oxidative Stress in Drug-Induced Liver Injury (DILI): From Mechanisms to Biomarkers for Use in Clinical Practice. | Antioxidants (Basel) | 2021 | https://conductscience.org/library/papers/33807700 | PubMed |
| 33799477 | Idiosyncratic Drug-Induced Liver Injury: Mechanistic and Clinical Challenges. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/33799477 | PubMed |
| 33178178 | Etiopathogenesis, Challenges and Remedies Associated With Female Genital Tuberculosis: Potential Role of Nuclear Receptors. | Front Immunol | 2020 | https://conductscience.org/library/papers/33178178 | PubMed |
| 32735603 | Expression of type I collagen in response to Isoniazid exposure is indirect and is facilitated by collateral induction of cytochrome P450 2E1: An in-vitro study. | PLoS One | 2020 | https://conductscience.org/library/papers/32735603 | PubMed |
| 32550793 | Determination of isoniazid acetylation patterns in tuberculosis patients receiving DOT therapy under the Revised National tuberculosis Control Program (RNTCP) in India. | Saudi Pharm J | 2020 | https://conductscience.org/library/papers/32550793 | PubMed |
| 32373368 | Isoniazid and Rifampicin Produce Hepatic Fibrosis through an Oxidative Stress-Dependent Mechanism. | Int J Hepatol | 2020 | https://conductscience.org/library/papers/32373368 | PubMed |
| 32324077 | What have we learned from animal models of idiosyncratic, drug-induced liver injury? | Expert Opin Drug Metab Toxicol | 2020 | https://conductscience.org/library/papers/32324077 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/766682
GET https://conductscience.org/api/papers/v1/766682/cited_by?page=2